CCR7 and head and neck squamous cell carcinoma: The results showed that treatment with CCR7 mAb completely abrogated the CCL19-dependent activation of STAT3 (Figure 3), indicating that CCR7's activation stimulated the phosphorylation of STAT3 in SCCHN cells.